| Literature DB >> 35651370 |
Hedi Zhao1,2, Sukhdeep Jatana1,2, Jessica Bartoszko3, Mark Loeb4.
Abstract
Background: Respiratory viruses pose an important public health threat to most communities. Nonpharmaceutical interventions (NPIs) such as masks, hand hygiene or physical distancing, among others, are believed to play an important role in reducing transmission of respiratory viruses. In this umbrella review, we summarise the evidence of the effectiveness of NPIs for the prevention of respiratory virus transmission in the community setting. Observations: A systematic search of PubMed, Embase, Medline and Cochrane reviews resulted in a total of 24 studies consisting of 11 systematic reviews and meta-analyses, 12 systematic reviews without meta-analyses and one standalone meta-analysis. The current evidence from these data suggests that hand hygiene is protective against respiratory viral infection. The use of hand hygiene and facemasks, facemasks alone and physical distancing were interventions with inconsistent evidence. Interventions such as school closures, oral hygiene or nasal saline rinses were shown to be effective in reducing the risk of influenza; however, the evidence is sparse and mostly of low and critically low quality. Conclusions: Studies on the effectiveness of NPIs for the prevention of respiratory viral transmission in the community vary in study design, quality and reported effectiveness. Evidence for the use of hand hygiene or facemasks is the strongest; therefore, the most reasonable suggestion is to use hand hygiene and facemasks in the community setting.Entities:
Year: 2022 PMID: 35651370 PMCID: PMC9149389 DOI: 10.1183/23120541.00650-2021
Source DB: PubMed Journal: ERJ Open Res ISSN: 2312-0541
Inclusion and exclusion criteria
|
|
| |
|
| Community setting ( | Healthcare workers (including dentists, mainly taking place in clinics) |
|
| Any nonpharmaceutical intervention ( | Pharmaceutical interventions ( |
|
| No intervention or control | |
|
| Self-reported or clinically diagnosed ARI, ILI, CRI | Bacterial infection, fungal infection, parasitic infection |
|
| English | Language other than English |
|
| Systematic reviews of interventional, observational, epidemiological studies | Nonsystematic reviews, systematic reviews containing modelling or simulation studies, umbrella reviews, meta-reviews |
|
| 1 January 2020 to 31 December 2020 | Before 1 January 2020 or after 31 December 2020 |
|
| Must have at least two contributing authors | Single author, full text unretrievable |
ARI: acute respiratory illness; ILI: influenza-like illness; CRI: clinical respiratory infection.
FIGURE 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram for the identification of systematic reviews and meta-analyses. CINAHL: Cumulative Index to Nursing and Allied Health database.
Systematic reviews and meta-analyses
|
|
|
|
|
|
|
|
|
| ||||||
| C | 172 | 3/44 | General community# | Facemask | Probable or confirmed SARS-CoV-1 infection | Facemask use by those exposed to infected contacts decreases the risk of infection (relative risk 0.56, 95% CI 0.40–0.79; low–moderate credibility) |
| J | 67 | 16/35 | School | Hand hygiene | ARI | Hand hygiene decreases the composite outcome of ARI, ILI or laboratory-confirmed influenza relative to control (risk ratio 0.89, 95% CI 0.84–0.95; low-certainty evidence) with high heterogeneity |
| Facemask | Mask results were not differentiated between community and healthcare settings | |||||
| Facemask and hand hygiene | Hand hygiene with facemasks does not reduce the risk of ILI (risk ratio 1.03, 95% C1 0.77–1.37) or laboratory-confirmed influenza (risk ratio 0.99, 95% CI 0.69–1.36) compared to control | |||||
| Gargling | Gargling does not reduce the risk of viral illness compared to control (risk ratio 0.91, 95% CI 0.63–1.31) | |||||
| W | 18 | 10/10 RCTs | Household | Hand hygiene | ILI | Hand hygiene alone compared to control does not demonstrate a significant benefit for ILI (risk ratio 0.86, 95% CI 0.71–1.04) and laboratory-confirmed influenza (risk ratio 0.90, 95% CI 0.67–1.20) |
| Hand hygiene and facemask | Hand hygiene with facemask use compared to control is associated with significantly decreased ILI (risk ratio 0.73, 95% CI 0.6–0.89) and laboratory-confirmed influenza (risk ratio 0.73, 95% CI 0.53–0.99) | |||||
| Hand hygiene ± facemask | Hand hygiene with or without facemask compared to control is associated with a significant decrease in ILI (risk ratio 0.78, 95% CI 0.68–0.9), but a nonsignificant effect on laboratory-confirmed influenza (risk ratio 0.82, 95% CI 0.66–1.02) | |||||
|
| ||||||
| A | 17 | 7/7 RCTs and observational studies | Low- to middle-income countries (China, Bangladesh, Thailand) | Facemask | SARS and influenza incidence | Facemask use demonstrates no significant benefit to the composite of influenza and SARS spread |
| Hand hygiene | Hand hygiene demonstrates no significant benefit to SARS and influenza spread | |||||
| Facemask and hand hygiene | Facemasks with hand hygiene demonstrates no significant benefit to influenza spread | |||||
| Social distancing | Social distancing interventions may slow down the spread of influenza (low-certainty evidence, 9 studies not pooled) | |||||
| A | 9 | 8/9 | Household | Facemask | Clinically diagnosed influenza or ILI | Facemasks show no significant reduction of ILI compared to control (effect size −0.17, 95% CI −0.43–0.10)¶ |
| Facemask and hand hygiene | Mask and hand hygiene show no significant reduction of ILI compared to control (effect size −0.09, 95% CI −0.58–0.4)¶ | |||||
| G | 41 | 8/34 | Low- to middle-income countries | Hand hygiene | ARI | Hand hygiene compared to control decreases the risk of ARI (risk ratio 0.76, 95% CI 0.59–0.98), 6 studies, moderate-quality evidence |
| L | 21 | 8/8 RCTs and observational studies | School | Facemask | Laboratory confirmed respiratory virus | Facemask use compared to control significantly reduces laboratory-confirmed viral infection by 47% (OR 0.53, 95% CI 0.36–0.79) |
| R | 8 | 8/8 | School | Hand hygiene | ARI | Hand hygiene measures lower risk of respiratory infection by 24% (relative risk 0.76, 95% CI 0.6–0.96) |
| R | 37 | 10 personal protective equipment | Assisted-living facility | Personal protective equipment (hand hygiene, mask, droplet precautions) | ILI with minor variations | Personal protective equipment is not associated with decreased influenza A or B attack rate (OR 0.63, 95% CI 0.33–1.19) |
| 18 social distancing | Social distancing (no new admissions, visitor restriction, ward transfer restrictions, isolation or cohorting) | Social distancing is not associated with decreased influenza A or B attack rate (OR 1.31, 95% CI 0.78–2.18) | ||||
| W | 15 | 10/10 observational studies | School | Facemask ± hand hygiene | ARI | Facemask use is not associated with reduced ARI incidence (OR 0.96, 95% CI 0.8–1.15) |
| X | 18 | 12/12 hand-hygiene studies | School | Facemask and hand hygiene | Laboratory-confirmed influenza | Facemask use with hand hygiene does not significantly decrease laboratory-confirmed influenza (risk ratio 0.91, 95% CI 0.73–1.13; 6 studies) |
| Facemask | Facemask use alone does not significantly decrease laboratory-confirmed influenza (risk ratio 0.78, 95% CI 0.51–1.20; 7 studies) | |||||
| Facemask ± hand hygiene | Facemask use with or without hand hygiene does not decrease laboratory-confirmed influenza (risk ratio 0.92, 95% CI 0.75–1.12; 10 studies) | |||||
| Hand hygiene | No pooled estimate for hand hygiene alone or with optional facemask use due to high heterogeneity |
SARS-CoV: severe acute respiratory syndrome coronavirus; ARI: acute respiratory illness; ILI: influenza-like illness; RCT: randomised controlled trial. #: general community settings refer to all other community-based settings not fitting into any of the major categories such as school, household, assisted living facility, childcare centre or workplace. ¶: the effect size was calculated as log(OR). A negative number represents a protective effect.
Systematic review only
|
|
|
|
|
|
|
|
| |||||
| M | 14/14 | Low- to middle-income countries | Hand hygiene (education, promotion and infrastructure) | ARI | Hand-hygiene interventions can reduce ARI morbidity in childcare, school and domestic settings, but depend on setting, intervention target and compliance |
| M | 16/16 | Household | Hand hygiene | Laboratory-confirmed influenza | Effectiveness of hand hygiene against influenza virus infection and transmission in community settings is difficult to determine due to heterogeneity and poor quality of evidence |
| S | 6/7 | School | Hand hygiene | ILI | Handwashing appears to be helpful in decreasing viral transmission |
| Facemask | Not able to fully assess, secondary to significant design flaws | ||||
| Combination NPIs (one or more of hand hygiene, facemask, education) | Not able to fully assess, secondary to significant design flaws | ||||
| Education as component of other NPI interventions | An NPI approach with an educational component (education, guidance or advice) appears to be effective in decreasing viral transmission | ||||
| Gargling/oral hygiene | Oral hygiene appears to be helpful in decreasing viral transmission | ||||
| W | 13/18 | School (ages 3–11 years) | Hand hygiene | Incidence of respiratory tract infections (composite) | Hand hygiene may reduce respiratory tract infection incidence, laboratory-confirmed respiratory tract infection and sick leave |
|
| |||||
| C | 15/39 | School | Facemasks | SARS-CoV-1 infection | No studies of mask effectiveness for prevention of SARS-CoV-2 in the community |
| C | 5/12 | School | Facemask | ILI | Some evidence to support that wearing masks or respirators is beneficial in preventing influenza transmission if worn during illness |
| F | 57/101 | School | School closure in Asia, Europe, America, Africa, and Australia | Effectiveness of school closure (poorly defined) | Planned school closure (holiday) may decrease influenza transmission during closure, but leads to increase after opening |
| M | 11/19 | School | Facemasks ± hand hygiene | ILI | In community settings, masks appear to be effective with and without hand hygiene, and both together are more protective; interventions appear to be more likely to be more effective if used within 36 h of exposure |
| M | 8/8 | Developing countries | Hand hygiene (education, promotion and infrastructure) | ARI | Hand hygiene compared to control decreases ARI (risk ratio 0.77, 95% CI 0.62–0.95) |
| S | 7/8 | School | Nasal wash with isotonic/hypertonic solutions | CRI | Hypertonic saline gargles and nasal wash may help prevent or improve symptoms of respiratory illness, reduce transmission, reduce need for medication and reduce viral loads in patients with common cold |
| W | 9/19 | School (ages 4–15 years) | Hand hygiene | Sick leave secondary to respiratory illness | Inadequate evidence to show that hand-hygiene interventions have an effect on ARI-associated sick leave; note, 5 out of 9 studies show hand-hygiene intervention has significant reduction in ARI-associated sick leave compared to control (30.9–52.6% reduction) |
| W | 16/16 | School | Hand hygiene | ILI | Hand hygiene interventions have the potential to reduce influenza and ARI, but their effectiveness depends on setting, context and compliance |
ARI: acute respiratory illness; ILI: influenza-like illness; RCT: randomised controlled trial; NPI: nonpharmaceutical intervention; SARS-CoV: severe acute respiratory syndrome coronavirus; MERS-CoV: Middle East respiratory syndrome coronavirus; CRI: clinical respiratory infection; URTI: upper respiratory tract infection. #: general community settings refer to all other community-based settings not fitting into any of the major categories such as school, household, assisted living facility, childcare centre or workplace.
Meta-analyses only
|
|
|
|
|
|
|
|
| |||||
| A | 13/30 | School | Hand hygiene | Reported or diagnosed respiratory illness | All hand hygiene interventions |
#: general community settings refer to all other community-based settings not fitting into any of the major categories such as school, household, assisted living facility, childcare centre or workplace.
Summary of study findings for reducing respiratory viral transmission
|
|
|
|
|
|
|
|
|
|
|
| SR+MA | L | Probable or confirmed SARS-CoV-1 relative risk 0.56 (0.40–0.79) | n/a | n/a | n/a | n/a | n/a |
|
| SR+MA | L | n/a | ILI risk ratio 1.03 (0.77–1.37) | Composite risk ratio 0.89 (0.84–0.95) | n/a | n/a | Risk of viral illness risk ratio 0.91 (0.63–1.31) |
|
| SR+MA | L | n/a | ILI risk ratio 0.73 (0.6–0.89) | ILI risk ratio 0.86 (0.71–1.04) | n/a | n/a | n/a |
|
| SR+MA | CL | SARS and influenza spread risk ratio 0.78 (0.36–1.67) | Influenza spread risk ratio 0.94 (0.58–1.54) | SARS and influenza spread risk ratio 0.95 (0.83–1.05) | + | n/a | n/a |
|
| SR+MA | CL | n/a | ILI effect size# −0.09 (−0.58–0.4) | ILI effect size# −0.17 (−0.43–0.10) | n/a | n/a | n/a |
|
| SR+MA | CL | n/a | n/a | ARI risk ratio 0.76 (0.59–0.98) | n/a | n/a | n/a |
|
| SR+MA | CL | Viral infection OR 0.53 (0.36–0.79) | n/a | n/a | n/a | n/a | n/a |
|
| SR+MA | CL | n/a | n/a | Respiratory infection relative risk 0.76 (0.6–0.96) | n/a | n/a | n/a |
|
| SR+MA | CL | n/a | Influenza A or B attack rate OR 0.63 (0.33–1.19)¶ | n/a | Influenza A or B attack rate OR 1.31 (0.78–2.18) | n/a | n/a |
|
| SR+MA | CL | ARI OR 0.96 (0.8–1.15) | n/a | n/a | n/a | n/a | n/a |
|
| SR+MA | CL | Laboratory-confirmed influenza risk ratio 0.78 (0.51–1.20) | Laboratory-confirmed influenza risk ratio 0.91 (0.73–1.13) | n/a | n/a | n/a | n/a |
|
| SR | L | n/a | n/a | ++ | n/a | n/a | n/a |
|
| SR | L | n/a | n/a | + | n/a | n/a | n/a |
|
| SR | L | n/a§ | n/a§ | ++ | n/a | n/a | ++ |
|
| SR | L | n/a | n/a | ++ | n/a | n/a | n/a |
|
| SR | CL | − | n/a | n/a | n/a | n/a | n/a |
|
| SR | CL | + | n/a | n/a | n/a | n/a | n/a |
|
| SR | CL | n/a | n/a | n/a | n/a | ++ | n/a |
|
| SR | CL | ++ | ++ | n/a | n/a | n/a | n/a |
|
| SR | CL | n/a | n/a | ++ | n/a | n/a | n/a |
|
| SR | CL | n/a | n/a | n/a | n/a | n/a | + |
|
| SR | CL | n/a | n/a | + | n/a | n/a | n/a |
|
| SR | CL | n/a | n/a | ++ | n/a | n/a | n/a |
|
| MA | CL | n/a | n/a | Reduction in respiratory illness 21% (5–34%) | n/a | n/a | n/a |
Includes study type and AMSTAR (A Measurement Tool to Assess Systematic Reviews) 2 rating. Data are presented as ratio value (95% CI), unless otherwise stated. SR: systematic review; MA: meta-analysis; SARS-CoV: severe acute respiratory syndrome coronavirus; n/a: not applicable; ILI: influenza-like illness; ARI: acute respiratory illness; L: low quality; CL: critically low quality; ++: findings suggest positive effect; +: findings suggest potential positive effect; −: findings suggest no effect/neutral effect. #: effect size=log(OR); ¶: personal protective equipment as an intervention was categorised as masks+hand hygiene; §: no clear summary statement and not able to fully assess, because of methodological flaws in studies included in systematic review.